Trial intelligence / Profile preview

Granisetron vs Ondansetron for Hemodynamics and Shivering in Cesarean Delivery

NCT06437236Recruiting

Sponsor
Sohag University
Start
Apr 2024
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of granisetron in hemodynamic instability (2 arms), sponsored by Sohag University. Primary endpoint: Blood pressure measurement at 6 months. Started Apr 2024; status: recruiting.

02

Drugs

granisetron
03

Conditions

hemodynamic instability

Beyond the preview

Go deeper on NCT06437236.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06437236.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call